Showing results (171-180 of 5,471) with videos related to
Sort By:
Pageof 548
International Journal of Hematology|April 30, 2015
Curative haploidentical BMT in a murine model of X-linked chronic granulomatous diseaseYasuo Takeuchi, Emiko Takeuchi, Takashi Ishida, et al.International Journal of Hematology|May 13, 2020
Real-world, retrospective study evaluating thromboembolic events, associated risk factors, and health-care resource utilization in Japanese patients with polycythemia veraNorio Komatsu, GyungJin Jun, Toshio Yonezu, et al.International Journal of Hematology|December 24, 1997
Infections in patients with hematological diseases: recent advances in serological diagnosis and empiric therapyM YoshidaInternational Journal of Hematology|December 24, 1997
HLA DR2: a predictive marker in response to cyclosporine therapy in aplastic anemiaO Ihan, M Beksaç, O Arslan, et al.International Journal of Hematology|December 24, 1997
A case of mu-heavy chain disease: combined features of mu-chain disease and macroglobulinemiaT Iwasaki, T Hamano, K Kobayashi, et al.International Journal of Hematology|April 11, 2020
Megakaryocytes in peripheral blood smears of non-hematological diseasesJianfeng Zhu, Wei Guo, Beili WangInternational Journal of Hematology|October 23, 2019
Novel lysyl oxidase inhibitors attenuate hallmarks of primary myelofibrosis in miceOrly Leiva, Seng Kah Ng, Shinobu Matsuura, et al.International Journal of Hematology|August 18, 2021
Serial evaluation of the pharmacokinetics of ponatinib in patients with CML and Ph + ALLNoriaki Kawano, Shinya Kimura, Masatomo Miura, et al.International Journal of Hematology|August 11, 2021
Chronic liver graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients during tapering or after stopping calcineurin inhibitorsKazuki Yoshimura, Shun-Ichi Kimura, Masakatsu Kawamura, et al.International Journal of Hematology|August 12, 2021
Vemurafenib provides a rapid and robust clinical response in pediatric Langerhans cell histiocytosis with the BRAF V600E mutation but does not eliminate low-level minimal residual disease per ddPCR using cell-free circulating DNADmitry Evseev, Irina Kalinina, Elena Raykina, et al.Pageof 548